Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Consolidated Edison
ED
$39.3B
| $1.03M | 0.04% |
17,800
-6,000
| -25% | -$335K |
|
202
Allison Transmission
ALSN
$11B
| $1.01M | 0.04% |
32,505
+11,532
| +55% | +$348K |
|
|
XLS
203
DELISTED
EXELIS INC COM STK
XLS
| $1.01M | 0.04% |
63,780
+34,945
| +121% | +$576K |
|
204
Bankunited
BKU
$3.3B
| $997K | 0.04% |
29,786
+830
| +3% | +$27.5K |
|
205
Valero Energy
VLO
$100B
| $995K | 0.04% |
19,866
+6,472
| +48% | +$357K |
|
206
Southwest Airlines
LUV
$19.8B
| $994K | 0.04% |
37,000
-4,600
| -11% | -$116K |
|
207
CNA Financial
CNA
$13.3B
| $991K | 0.04% |
24,518
+18,518
| +309% | +$759K |
|
208
Kroger
KR
$35.5B
| $989K | 0.04% |
40,000
-12,800
| -24% | -$298K |
|
|
SN
209
DELISTED
Sanchez Energy Corporation
SN
| $989K | 0.04% |
26,300
-6,383
| -20% | -$201K |
|
210
CONMED
CNMD
$1.53B
| $988K | 0.04% |
22,370
-2,553
| -10% | -$116K |
|
|
AHL
211
DELISTED
ASPEN Insurance Holding Limited
AHL
| $986K | 0.04% |
21,700
+3,353
| +18% | +$150K |
|
|
HLSS
212
DELISTED
HOME LN SERVICING SOLUTIONS LTD(CAYMAN ISLANDS)
HLSS
| $977K | 0.04% |
43,000
-33,355
| -44% | -$737K |
|
213
Devon Energy
DVN
$54B
| $971K | 0.04% |
12,232
-1,390
| -10% | -$101K |
|
214
GATX Corp
GATX
$6.25B
| $971K | 0.04% |
14,500
+10,800
| +292% | +$706K |
|
|
LPNT
215
DELISTED
LifePoint Health, Inc.
LPNT
| $969K | 0.04% |
15,600
+1,900
| +14% | +$111K |
|
216
Charles River Laboratories
CRL
$14.1B
| $968K | 0.04% |
18,094
+1,333
| +8% | +$73.1K |
|
217
Otter Tail
OTTR
$3.81B
| $967K | 0.04% |
31,936
+2,100
| +7% | +$61.1K |
|
218
State Street
STT
$51.4B
| $967K | 0.04% |
14,374
+2,501
| +21% | +$164K |
|
|
SYKE
219
DELISTED
SYKES Enterprises Inc
SYKE
| $966K | 0.04% |
44,472
-5,328
| -11% | -$108K |
|
|
UNT
220
DELISTED
UNIT Corporation
UNT
| $962K | 0.04% |
13,980
+5,763
| +70% | +$376K |
|
|
WBA
221
DELISTED
Walgreens Boots Alliance
WBA
| $959K | 0.04% |
12,930
-7,016
| -35% | -$490K |
|
222
Northrop Grumman
NOC
$78.3B
| $957K | 0.04% |
7,997
+5,880
| +278% | +$711K |
|
|
MAGN
223
Magnera Corp
MAGN
$439M
| $954K | 0.04% |
2,766
+686
| +33% | +$234K |
|
|
AY
224
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $946K | 0.04% |
+25,000
| New | +$946K |
|
|
VIAB
225
DELISTED
Viacom Inc. Class B
VIAB
| $945K | 0.04% |
+10,896
| New | +$926K |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.